News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,115 Results
Type
Article (69688)
Company Profile (154)
Press Release (645265)
Multimedia
Podcasts (180)
Webinars (29)
Section
Business (194674)
Career Advice (2287)
Deals (32150)
Drug Delivery (146)
Drug Development (76694)
Employer Resources (145)
FDA (16496)
Job Trends (14849)
News (328272)
Policy (32144)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2980)
Academic (2)
Accelerated approval (50)
ADA (44)
Adcomms (32)
Allergies (200)
Alliances (50910)
ALS (221)
Alzheimer's disease (1873)
Antibody-drug conjugate (ADC) (507)
Approvals (16930)
Artificial intelligence (802)
ASCO (311)
Autoimmune disease (338)
Automation (53)
Bankruptcy (288)
Best Places to Work (11219)
BIOSECURE Act (22)
Biosimilars (214)
Biotechnology (103)
Bladder cancer (195)
Brain cancer (79)
Breast cancer (797)
Cancer (6212)
Cardiovascular disease (506)
Career advice (1965)
Career pathing (43)
CAR-T (349)
CDC (67)
Celiac Disease (3)
Cell therapy (965)
Cervical cancer (54)
Clinical research (66450)
Collaboration (2289)
Commercialization (1)
Company closure (3)
Compensation (751)
Complete response letters (74)
COVID-19 (2840)
CRISPR (113)
C-suite (1179)
Cystic fibrosis (148)
Data (8321)
Decentralized trials (3)
Denatured (63)
Depression (184)
Dermatology (86)
Diabetes (645)
Diagnostics (6797)
Digital health (66)
Diversity (12)
Diversity, equity & inclusion (39)
Drug discovery (390)
Drug pricing (209)
Drug shortages (34)
Duchenne muscular dystrophy (289)
Earnings (82506)
Editorial (77)
Employer branding (20)
Employer resources (132)
Events (104238)
Executive appointments (1096)
FDA (20348)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1810)
Gene editing (235)
Generative AI (76)
Gene therapy (754)
GLP-1 (1155)
Government (4958)
Grass and pollen (7)
Guidances (411)
Healthcare (18861)
Hematology (179)
HIV (91)
Huntington's disease (53)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (107)
Immunology and inflammation (287)
Immuno-oncology (107)
Indications (199)
Infectious disease (3197)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (290)
Interviews (414)
IPO (14071)
IRA (56)
Job creations (3913)
Job search strategy (1630)
JPM (67)
Kidney cancer (20)
Labor market (99)
Layoffs (564)
Leadership (40)
Legal (7737)
Liver cancer (107)
Longevity (32)
Lung cancer (827)
Lymphoma (460)
Machine learning (63)
Management (48)
Manufacturing (1089)
Marketing (1)
MASH (215)
Medical affairs (1)
Medical device (14752)
Medtech (14914)
Mergers & acquisitions (19266)
Metabolic disorders (1661)
mRNA (243)
Multiple sclerosis (190)
NASH (19)
Neurodegenerative disease (463)
Neuropsychiatric disorders (115)
Neuroscience (3489)
Neurotech (1)
NextGen: Class of 2026 (6486)
Non-profit (4850)
Now hiring (68)
Obesity (774)
Opinion (328)
Ovarian cancer (238)
Pain (267)
Pancreatic cancer (331)
Parkinson's disease (395)
Partnered (39)
Patents (586)
Patient recruitment (726)
Peanut (67)
People (57646)
Pharmaceutical (33)
Pharmacy benefit managers (32)
Phase 1 (20391)
Phase 2 (28866)
Phase 3 (22239)
Pipeline (9456)
Policy (359)
Postmarket research (2819)
Preclinical (9336)
Press Release (70)
Prostate cancer (343)
Psychedelics (67)
Radiopharmaceuticals (352)
Rare diseases (1121)
Real estate (5967)
Recruiting (62)
Regulatory (25070)
Reports (45)
Research institute (2722)
Resumes & cover letters (347)
Rett syndrome (35)
RNA editing (27)
RSV (92)
Schizophrenia (191)
Series A (301)
Series B (208)
Service/supplier (13)
Sickle cell disease (119)
Special edition (30)
Spinal muscular atrophy (169)
Sponsored (47)
Startups (3617)
State (1)
Stomach cancer (19)
Supply chain (129)
Tariffs (99)
The Weekly (114)
Vaccines (1213)
Venture capital (126)
Weight loss (522)
Women's health (124)
Worklife (20)
Date
Today (103)
Last 7 days (444)
Last 30 days (2529)
Last 365 days (28932)
2026 (14617)
2025 (28882)
2024 (33168)
2023 (37662)
2022 (48658)
2021 (52855)
2020 (51725)
2019 (45768)
2018 (34924)
2017 (32177)
2016 (32057)
2015 (37298)
2014 (30922)
2013 (27689)
2012 (28510)
2011 (28569)
2010 (27292)
Location
Africa (953)
Alabama (97)
Alaska (6)
Arizona (328)
Arkansas (13)
Asia (43351)
Australia (7457)
California (12170)
Canada (3603)
China (1492)
Colorado (571)
Connecticut (592)
Delaware (424)
Europe (98564)
Florida (1926)
Georgia (431)
Hawaii (2)
Idaho (60)
Illinois (1105)
India (99)
Indiana (626)
Iowa (23)
Japan (587)
Kansas (131)
Kentucky (55)
Louisiana (54)
Maine (51)
Maryland (1562)
Massachusetts (8724)
Michigan (391)
Minnesota (716)
Mississippi (7)
Missouri (134)
Montana (35)
Nebraska (28)
Nevada (132)
New Hampshire (92)
New Jersey (3524)
New Mexico (33)
New York (3428)
North Carolina (1722)
North Dakota (11)
Northern California (6046)
Ohio (406)
Oklahoma (23)
Oregon (38)
Pennsylvania (2509)
Puerto Rico (26)
Rhode Island (52)
South America (1266)
South Carolina (86)
Southern California (4883)
Tennessee (219)
Texas (2081)
United States (44890)
Utah (407)
Vermont (1)
Virginia (327)
Washington D.C. (84)
Washington State (1051)
West Virginia (4)
Wisconsin (137)
Wyoming (2)
715,115 Results for "bill and melinda gates medical research institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Dr. Patrice Matchaba Appointed as Chief Executive Officer of the Bill & Melinda Gates Medical Research Institute
The Bill & Melinda Gates Medical Research Institute announced the appointment of Patrice Matchaba, MD, as Chief Executive Officer, starting June 10, 2024.
May 28, 2024
·
3 min read
Press Releases
SK bioscience In-Licenses RSV Preventive mAb Candidate from Gates Medical Research Institute
February 3, 2026
·
5 min read
Press Releases
Federal Funding Bill Commits $3 Million to Versiti Blood Research Institute Expansion
February 5, 2026
·
2 min read
BioCapital
Novavax Announces Agreement with Bill & Melinda Gates Medical Research Institute to Include Matrix-M™ Adjuvant as Potential Component in Vaccine Research
Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, has signed a three-year agreement with the Bill & Melinda Gates Medical Research Institute to provide its adjuvant for use in preclinical vaccine research.
June 5, 2023
·
4 min read
Biotech Beach
Calibr and Bill & Melinda Gates Medical Research Institute announce licensing agreement for novel candidate tuberculosis treatment compound
Calibr, a division of Scripps Research dedicated to the “bench to bedside” development of transformative medicines, and the Bill & Melinda Gates Medical Research Institute, announced a strategic licensing agreement to advance development of a novel investigational compound for tuberculosis treatment.
February 15, 2023
·
4 min read
Pharm Country
Merck and the Bill & Melinda Gates Medical Research Institute Announce Licensing Agreement for Novel Tuberculosis Antibiotic Candidates
Merck, known as MSD outside of the United States and Canada, and the Bill & Melinda Gates Medical Research Institute announced a licensing agreement for two preclinical antibacterial candidates for evaluation as potential components of combination regimens for the treatment of tuberculosis.
October 18, 2022
·
6 min read
Press Releases
EverythingALS and Vision 2030 Invest in Allen Institute Initiative to Accelerate ALS Research
June 3, 2026
·
6 min read
Press Releases
TrialAssure and Cancer Research UK Collaborate to Advance AI-Supported Regulatory Document Authoring
Cancer Research UK’s Centre for Drug Development is using TrialAssure LINK AI to support medical writing in CRUK-sponsored studies
June 18, 2026
·
1 min read
Press Releases
The University of Colorado Anschutz Gates Institute Achieves First-in-U.S. FDA Clearance for Campus-Built CAR T-Cell Therapy
April 3, 2026
·
4 min read
Press Releases
Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer
May 20, 2026
·
2 min read
1 of 71,512
Next
